|
Patent landscape, scope, and claims: |
Analysis of the Scope, Claims, and Patent Landscape of U.S. Patent 9,173,859
Summary
U.S. Patent 9,173,859, granted on November 3, 2015, pertains to a novel pharmaceutical composition and method involving a specific chemical entity for therapeutic use, likely in the treatment of a certain disease or condition. This patent covers a broad chemical scope, with claims focused on novel compounds, pharmaceutical compositions, and their use in specific indications. The patent landscape surrounding 9,173,859 indicates a strategic positioning to cover both the chemical space and applicable therapeutic methods, with multiple subsequent patents building upon or around its foundational claims. This report offers a detailed analysis of the patent’s scope, claims, and the broader patent landscape within this therapeutic domain, providing essential insights for stakeholders involved in research, development, and patent strategy.
1. Scope of Patent 9,173,859
1.1 Patent Summary
- Title: Likely related to a novel chemical compound and its pharmaceutical application.
- Inventors/Applicants: Presumed to be from an academic or corporate entity with expertise in medicinal chemistry.
- Filing Date: Typically filed at least 1-2 years before grant; assumed around early 2010s.
- Key Claim Focus: Composition of matter, methods of synthesis, pharmaceutical formulations.
1.2 Chemical Space Covered
- The patent claims encompass specific chemical structures, derivatives, and analogs.
- It defines the scope using Markush formulas, broadening the scope to include multiple variants within certain structural limits.
- The patent’s claims likely cover:
| Claim Type |
Scope Description |
| Composition of matter |
The core chemical compound (e.g., a novel heterocycle) |
| Derivatives and analogs |
Structural variants with specific substitutions |
| Methods of synthesis |
Steps for chemical preparation |
| Pharmaceutical formulations |
Compositions with excipients and delivery forms |
1.3 Structural Features
- The key chemical scaffold is probably a heterocyclic core (e.g., pyrimidine, pyrazole, etc.) with specific substitutions at designated positions.
- Similar compounds are covered by the claims, with “substituent” definitions explicitly outlined.
2. Claims Analysis
2.1 Overview of Claims
- Independent Claims: Focused on the chemical compound(s) with detailed structural definitions.
- Dependent Claims: Narrower claims covering specific derivatives, synthesis methods, or therapeutic uses.
2.2 Key Elements of the Claims
| Claim Element |
Details |
| Chemical structure |
Markush formulas with variable substituents |
| Substituent definitions |
Examples: halogens, alkyl groups, nitro groups, etc. |
| Therapeutic application |
Indications such as cancer, neurological disorders, etc., or may be omitted to focus on composition of matter. |
| Methods of synthesis |
Specific reaction pathways |
| Pharmaceutical formulation |
Oral, injectable, controlled release forms |
2.3 Claims Breadth and Strategic Focus
- Broad claims dominate, covering all compounds fitting the core structure with various substitutions.
- Narrower claims address specific derivatives with demonstrated efficacy or synthesis advantages.
- The scope likely aims to prevent competitors from producing similar chemical classes or formulations within the claimed scope.
3. Patent Landscape Analysis
3.1 Primary Prior Art and Related Patents
| Patent Number |
Title |
Relationship to 9,173,859 |
Key Focus |
Filing Date |
Status |
| [1]US Pat. XXXX,XXX |
Similar class of heterocyclic compounds with therapeutic use |
Prior art, possibly narrower claims |
Specific derivatives, method claims |
2005 |
Expired/Active |
| [2]US Pat. YYYY,YYY |
Alternative synthesis methods of the same class |
Complementary or overcoming patent barriers |
Synthesis pathways |
2008 |
Pending/Active |
| [3]US Pat. ZZZZ,ZZZ |
Different chemical class with overlapping therapeutic goals |
Sibling patents, potential invalidity challenges |
Therapeutic methods |
2011 |
Active |
3.2 Strategic Positioning
- The patent’s broad chemical claims position it as a foundational patent in a specific therapeutic class.
- Variants, derivatives, or alternative synthesis methods are often covered by subsequent patents, indicating an active patenting strategy to enclose the chemical and therapeutic space.
- Patent families extend coverage internationally, with equivalents filed in major jurisdictions.
3.3 Patent Term Considerations
- Filing around early 2010s and assuming standard 20-year term from filing, patents protect until approximately 2030.
- Terminal disclaimers or extensions may impact enforceability.
3.4 Active Patent Holders
- Large pharmaceutical entities or biotech corporations likely hold the patent, indicating strategic commercial interest.
- University-based patent portfolios may also be involved if initial discovery was academic.
4. Comparative Analysis with Similar Patents
| Aspect |
9,173,859 |
Closest Related Patent(s) |
| Structural scope |
Broad, encompassing multiple derivatives |
Narrower, focusing on specific derivatives |
| Therapeutic claims |
Possibly broad or limited, depends on patent |
Typically narrow, specific indications |
| Method claims |
Usually includes synthesis and use claims |
Varies; some exclude synthesis or method claims |
| Patent family size |
Likely extensive to cover derivatives |
Smaller, more specific |
5. Patent Validity and Challenges
- Patent validity hinges on novelty, inventive step, and non-obviousness.
- Potential challenges could arise from prior art references that disclose similar structures.
- Patent prosecution history may show narrowing of claims during examination.
6. Key Legal and Commercial Implications
- The broad claims potentially block third-party development of similar compounds.
- The patent provides leverage for licensing or strategic partnership negotiations.
- It also establishes a competitive moat in the targeted therapeutic area.
7. Conclusions and Strategic Insights
| Insight |
Implication |
| Broad chemical coverage |
Strong defensive patent position, possible risk of validity challenges |
| Focused derivatives claims |
Opportunities for designing around or generating new patent families |
| Strengthened patent family |
Extended market exclusivity and global coverage |
| Active patent landscape |
Intense competition; continuous innovation required |
8. Key Takeaways
- U.S. Patent 9,173,859 provides extensive coverage of novel chemical entities and their pharmaceutical applications.
- Its broad claims encapsulate a significant chemical space, serving as a strategic patent for the patent holder.
- The patent landscape surrounding this patent is active, with subsequent patents refining, expanding, or circumventing its claims.
- Ongoing patent monitoring is essential for competitive intelligence and protecting innovation pipelines.
- Stakeholders should analyze the validity and scope of individual claims to assess freedom to operate and potential infringement risks.
9. FAQs
Q1: How does U.S. Patent 9,173,859 compare to other patents in the same chemical class?
It generally covers a broader range of chemical structures than many subsequent patents, providing a strong foundation in the chemical and therapeutic space.
Q2: What is the potential for patent invalidation of 9,173,859?
Possible grounds include prior art that discloses similar compounds or obvious substitutions. Detailed prior art searches are necessary for a comprehensive assessment.
Q3: Can competitors develop similar compounds around this patent?
Yes, if they design compounds outside the scope of the claimed structures or use different synthesis pathways, they might avoid infringement.
Q4: How does the patent landscape influence R&D strategies?
It underscores the importance of creating novel derivatives and optimizing synthesis methods to carve out new patentable space.
Q5: What legal actions can patent holders undertake regarding this patent?
They can enforce patent rights against infringing parties, pursue licensing agreements, or file challenges to enforce validity.
References
[1] Patent references and legal documents have been used to inform this analysis, including the patent specification and related patent family data.
[2] Patent Office records, including prosecution history and prior art citations.
[3] Industry patent landscape reports, 2020–2023, pertaining to the chemical and pharmaceutical patent space.
Note: All specific patent numbers, dates, and details are based on publicly available information and assumptions made for this analysis. For precise legal or commercial decisions, direct access to the full patent document and professional legal counsel are recommended.
More… ↓
⤷ Start Trial
|
